CNFT gene therapy protects cone photoreceptors in a mouse model of retinitis pigmentosa Aug. 13, 2015 No Comments
Shire acquires Foresight Biotherapeutics and gains phase II conjunctivitis drug Aug. 4, 2015 No Comments
Caladrius Biosciences secures NIH grant to develop 3D retinal cell implants July 28, 2015 No Comments
RSS